SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001387131-19-004833
Filing Date
2019-07-03
Accepted
2019-07-03 16:03:50
Documents
4

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_062719.htm 425 50851
2 FIRST AMENDMENT, DATED AS OF JUNE 27, 2019, TO THE AGREEMENT AND PLAN OF MERGER ex2-1.htm EX-2.1 18582
3 PRESS RELEASE ex99-1.htm EX-99.1 23676
4 GRAPHIC ex99-1_img01.jpg GRAPHIC 2037
  Complete submission text file 0001387131-19-004833.txt   98002
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filed by) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 425 | Act: 34 | File No.: 001-35963 | Film No.: 19941922
SIC: 2834 Pharmaceutical Preparations